BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 18387776)

  • 1. Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations.
    Jin Y; Lin X; Li W; Hu X; Ma G; Wang W
    J Vasc Surg; 2008 Jun; 47(6):1292-9. PubMed ID: 18387776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital subtraction angiography-guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region.
    Li J; Chen J; Zheng G; Liao G; Fu Z; Li J; Zhang T; Su Y
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2258-66. PubMed ID: 20381941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with intralesional hemorrhage in venous malformations: diagnosis and embolosclerotherapy.
    Chen H; Lin X; Jin Y; Li W; Ma G; Hu X
    J Vasc Surg; 2009 Feb; 49(2):429-33; discussion 433-4. PubMed ID: 18945573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.
    Li L; Feng J; Zeng XQ; Li YH
    J Vasc Surg; 2009 Apr; 49(4):961-7. PubMed ID: 19341886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy.
    Spence J; Krings T; TerBrugge KG; Agid R
    Head Neck; 2011 Jan; 33(1):125-30. PubMed ID: 20848431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging.
    Yun WS; Kim YW; Lee KB; Kim DI; Park KB; Kim KH; Do YS; Lee BB
    J Vasc Surg; 2009 Sep; 50(3):581-9, 589.e1. PubMed ID: 19540703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digital subtraction angiography (DSA) guided sequential sclerotherapy for maxillofacial vein malformation.
    Meng J; Zhuang QW; Gu QP; Zhang J; Li ZP; Si YM
    Eur Rev Med Pharmacol Sci; 2014; 18(12):1709-12. PubMed ID: 24992611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation.
    Lee BB; Kim DI; Huh S; Kim HH; Choo IW; Byun HS; Do YS
    J Vasc Surg; 2001 Apr; 33(4):764-72. PubMed ID: 11296330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-saving isolation procedure in percutaneous ethanol sclerotherapy for venous malformations.
    Kishi K; Morita N; Terada T; Sato M
    Phlebology; 2014 Jun; 29(5):276-86. PubMed ID: 23508004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethanol sclerotherapy of peripheral venous malformations.
    Rimon U; Garniek A; Galili Y; Golan G; Bensaid P; Morag B
    Eur J Radiol; 2004 Dec; 52(3):283-7. PubMed ID: 15544907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous sclerotherapy using bleomycin for the treatment of vascular malformations.
    Lee HJ; Kim TW; Kim JM; Kim GW; Ko HC; Kim BS; Kim MB; Kim HS
    Int J Dermatol; 2017 Nov; 56(11):1186-1191. PubMed ID: 28869282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interim results of bleomycin-polidocanol foam sclerotherapy as a highly efficient technique for venous malformations.
    Yang X; Chen H; Gu H; Jin Y; Hu L; Hua C; Wang Y; Sun Y; Yu W; Lin X
    J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1066-1073. PubMed ID: 32284311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of venous malformations with sclerosant in microfoam form.
    Cabrera J; Cabrera J; Garcia-Olmedo MA; Redondo P
    Arch Dermatol; 2003 Nov; 139(11):1409-16. PubMed ID: 14623700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclerotherapy of peripheral venous malformations: a new technique to prevent serious complications.
    Ierardi AM; Mangini M; Vaghi M; Cazzulani A; Carrafiello G; Mattassi R
    Vasc Endovascular Surg; 2010 May; 44(4):282-8. PubMed ID: 20403950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results.
    Lee BB; Do YS; Byun HS; Choo IW; Kim DI; Huh SH
    J Vasc Surg; 2003 Mar; 37(3):533-8. PubMed ID: 12618688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicoradiologic predictors of sclerotherapy response in low-flow vascular malformations.
    Bagga B; Goyal A; Das A; Bhalla AS; Kandasamy D; Singhal M; Kairo A
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):209-219.e2. PubMed ID: 32653406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined surgery and sclerotherapy for massive venous malformations of the tongue].
    Huang X; Zou H; Guo X; Zhao Y
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Jan; 32(1):14-7. PubMed ID: 27197473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sclerotherapy of craniofacial venous malformations: complications and results.
    Berenguer B; Burrows PE; Zurakowski D; Mulliken JB
    Plast Reconstr Surg; 1999 Jul; 104(1):1-11; discussion 12-5. PubMed ID: 10597669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical study of sclerotherapy of maxillofacial venous malformation using absolute ethanol and pingyangmycin.
    Liu Y; Liu D; Wang Y; Zhang W; Zhao F
    J Oral Maxillofac Surg; 2009 Jan; 67(1):98-104. PubMed ID: 19070754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digital subtraction angiography-guided foam sclerotherapy of peripheral venous malformations.
    Li L; Zeng XQ; Li YH
    AJR Am J Roentgenol; 2010 May; 194(5):W439-44. PubMed ID: 20410391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.